Livforsakringsbolaget Skandia’s Edwards Lifesciences EW Stock Holding History

Livforsakringsbolaget Skandia’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$371K	Hold	4,637	–	–	0.01%	255
2025 Q4	$395K	Hold	4,637	–	–	0.02%	252
2025 Q3	$361K	Sell	4,637 -500	-10%	-$39.1K	0.01%	281
2025 Q2	$402K	Hold	5,137	–	–	0.02%	278
2025 Q1	$372K	Hold	5,137	–	–	0.02%	291
2024 Q4	$380K	Sell	5,137 -19,700	-79%	-$1.38M	0.02%	292
2024 Q3	$1.64M	Buy	24,837 +8,000	+48%	+$581K	0.09%	157
2024 Q2	$1.56M	Sell	16,837 -400	-2%	-$35.4K	0.13%	130
2024 Q1	$1.65M	Hold	17,237	–	–	0.14%	133
2023 Q4	$1.31M	Buy	17,237 +9,797	+132%	+$682K	0.13%	147
2023 Q3	$515K	Buy	7,440 +2,900	+64%	+$233K	0.06%	202
2023 Q2	$428K	Buy	4,540 +3,600	+383%	+$313K	0.04%	218
2023 Q1	$77.7K	Hold	940	–	–	0.01%	292
2022 Q4	$70.1K	Hold	940	–	–	0.01%	294
2022 Q3	$78K	Sell	940 -3,700	-80%	-$356K	0.01%	289
2022 Q2	$441K	Sell	4,640 -1,800	-28%	-$186K	0.04%	247
2022 Q1	$758K	Sell	6,440 -15,700	-71%	-$1.76M	0.05%	219
2021 Q4	$2.87M	Sell	22,140 -9,100	-29%	-$1.06M	0.18%	117
2021 Q3	$3.54M	Sell	31,240 -2,000	-6%	-$228K	0.22%	105
2021 Q2	$3.44M	Buy	33,240 +6,300	+23%	+$594K	0.21%	106
2021 Q1	$2.25M	Buy	26,940 +2,000	+8%	+$169K	0.16%	137
2020 Q4	$2.27M	Buy	24,940 +1,900	+8%	+$158K	0.19%	108
2020 Q3	$1.84M	Buy	23,040 +900	+4%	+$70.2K	0.2%	108
2020 Q2	$1.53M	Hold	22,140	–	–	0.17%	110
2020 Q1	$1.39M	Buy	22,140 +1,800	+9%	+$130K	0.2%	111
2019 Q4	$1.58M	Sell	20,340 -2,400	-11%	-$187K	0.19%	124
2019 Q3	$1.67M	Hold	22,740	–	–	0.2%	121
2019 Q2	$1.4M	Buy	22,740 +1,500	+7%	+$90.7K	0.17%	123
2019 Q1	$1.35M	Hold	21,240	–	–	0.18%	131
2018 Q4	$1.08M	Hold	21,240	–	–	0.16%	134
2018 Q3	$1.23M	Sell	21,240 -8,700	-29%	-$426K	0.15%	151
2018 Q2	$1.45M	Buy	29,940 +1,800	+6%	+$84K	0.13%	162
2018 Q1	$1.31M	Hold	28,140	–	–	0.13%	169
2017 Q4	$1.06M	Sell	28,140 -3,900	-12%	-$143K	0.1%	192
2017 Q3	$1.17M	Hold	32,040	–	–	0.1%	195
2017 Q2	$1.26M	Hold	32,040	–	–	0.12%	179
2017 Q1	$1M	Sell	32,040 -30,000	-48%	-$939K	0.09%	224
2016 Q4	$1.94K	Sell	62,040 -6,000	-9%	-$194K	0.1%	221
2016 Q3	$2.32M	Sell	68,040 -17,700	-21%	-$667K	0.11%	249
2016 Q2	$2.85M	Buy	85,740 +17,700	+26%	+$606K	0.13%	192
2016 Q1	$2M	Hold	68,040	–	–	0.09%	237
2015 Q4	$1.79M	Hold	68,040	–	–	0.08%	262
2015 Q3	$1.61M	Hold	68,040	–	–	0.08%	281
2015 Q2	$1.61M	Hold	68,040	–	–	0.08%	299
2015 Q1	$1.61M	Buy	68,040 +20,400	+43%	+$458K	0.08%	309
2014 Q4	$1.01M	Sell	47,640 -49,200	-51%	-$988K	0.05%	519
2014 Q3	$1.65M	Hold	96,840	–	–	0.06%	355
2014 Q2	$1.39M	Hold	96,840	–	–	0.05%	417
2014 Q1	$1.2M	Buy	+96,840	New	+$1.12M	0.05%	461

Other funds holding EW

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Livforsakringsbolaget Skandia's EW Position: Q1 2026 in Review

Livforsakringsbolaget Skandia held its Edwards Lifesciences (EW) position steady in Q1 2026 at 4,637 shares worth $371K. The position accounts for 0.01% of the portfolio, ranked #255.

Livforsakringsbolaget Skandia first reported a position in EW in Q1 2014 and has held it in 49 quarters since. The position peaked at $3.54M in Q3 2021. 1,287 funds tracked by Wall St. Rank hold EW as of Q1 2026.

Livforsakringsbolaget Skandia held 4,637 shares of Edwards Lifesciences worth $371K as of Q1 2026.
Livforsakringsbolaget Skandia left its Edwards Lifesciences share count unchanged in Q1 2026.
Edwards Lifesciences made up 0.01% of Livforsakringsbolaget Skandia's portfolio in Q1 2026, its #255 holding.
Livforsakringsbolaget Skandia first reported a position in Edwards Lifesciences in Q1 2014 and has held it in 49 quarters since.
Livforsakringsbolaget Skandia's Edwards Lifesciences position peaked at $3.54M in Q3 2021.
1,287 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Livforsakringsbolaget Skandia's 13F filing for Q1 2026, filed 5 May 2026.